The net profit of Vanda Pharmaceuticals according to GAAP for 6 months of 2021 amounted to $18.303 mln, having doubled as compared to $9.2 mln in the previous year. Revenue increased 8.6% to $130.568 million from $120.207 million a year earlier.
Warning BlackTerminal uses cookies in order to personalize and improve the usability of the service. If you do not want to use cookies, please change your browser settings. Accept